Genscript Biotech Stock

Genscript Biotech PEG

Delisted·Jun 18, 2026

PEG Ratio (Price/Earnings-to-Growth) of Genscript Biotech (1548.HK) as of Jul 21, 2026.

PEG

0.00

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Genscript Biotech is 2026 0.00 . PEG Ratio (Price/Earnings-to-Growth) of Genscript Biotech was 2025 0.04 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Genscript Biotech Stock analysis

What does Genscript Biotech do? GenScript Biotech Corp. is a leading biotechnology company founded in Nanjing, China in 2002. Today, it is headquartered in New Jersey, USA and operates worldwide. Genscript Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genscript Biotech stock

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Genscript Biotech since 2006 – with annual values, charts, and detailed analysis.

Access this data via the Eulerpool API

Valuation — Genscript Biotech

All Key Metrics — Genscript Biotech